Precigen Announces Dosing of First Patients with UltraCAR-T® Cells Manufactured Using Proprietary UltraPorator™ System in Ongoing PRGN-3005 and PRGN-3006 Phase 1 Clinical TrialsPRNewsWire • 11/16/20
ROSEN, A LEADING LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm - PGENewsfile Corp • 11/14/20
PGEN SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Investor Deadlines EstablishedNewsfile Corp • 11/03/20
PGEN SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON), Investors with Losses to Contact Its Attorneys, Securities Fraud Action Filed, Application Deadline ApproachingNewsfile Corp • 10/29/20
PGEN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Precigen, Inc. f/k/a Intrexon CorporationBusiness Wire • 10/29/20
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm - PGEN, XONNewsfile Corp • 10/29/20
Pomerantz Law Firm Announces the Filing of a Class Action against Precigen, Inc. f/k/a Intrexon Corporation Certain Officers - PGENPRNewsWire • 10/26/20
DEADLINE REMINDER: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)PRNewsWire • 10/26/20
ROSEN, A LEADING LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important December 4 Deadline in First Filed Securities Class Action Commenced by the Firm - PGEN, XONNewsfile Corp • 10/23/20
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON)PRNewsWire • 10/21/20
Precigen Strengthens Focus on Strategic Partnerships and Names Gaurav Vij Head of Business DevelopmentPRNewsWire • 10/20/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Precigen, Inc. (PGEN), f/k/a Intrexon Corp. (XON) Investors with Losses to Contact Its Attorneys, Securities Fraud Action FiledNewsfile Corp • 10/16/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) InvestorsPRNewsWire • 10/16/20
Precigen's UltraPorator™ Receives FDA Clearance for Manufacturing UltraCAR-T® Cells in Clinical TrialsPRNewsWire • 10/15/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm -- PGEN, XONPRNewsWire • 10/12/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/12/20
Rosen, A Globally Recognized Firm, Reminds Precigen, Inc. f/k/a Intrexon Corporation Investors of Important Deadline in Securities Class Action First Filed by the Firm - PGEN, XONNewsfile Corp • 10/09/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Precigen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/09/20
Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible NotePRNewsWire • 10/09/20
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, First Files Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon Corporation - PGEN, XONPRNewsWire • 10/08/20
